Page last updated: 2024-10-21

meglutol and Hyperlipemia

meglutol has been researched along with Hyperlipemia in 1 studies

Meglutol: An antilipemic agent which lowers cholesterol, triglycerides, serum beta-lipoproteins and phospholipids. It acts by interfering with the enzymatic steps involved in the conversion of acetate to hydroxymethylglutaryl coenzyme A as well as inhibiting the activity of HYDROXYMETHYLGLUTARYL COA REDUCTASES which is the rate limiting enzyme in the biosynthesis of cholesterol.
3-hydroxy-3-methylglutaric acid : A dicarboxylic acid that is glutaric acid in which one of the two hydrogens at position 3 is substituted by a hydroxy group, while the other is substituted by a methyl group. It has been found to accumulate in urine of patients suffering from HMG-CoA lyase (3-hydroxy-3-methylglutaryl-CoA lyase, EC 4.1.3.4) deficiency. It occurs as a plant metabolite in Crotalaria dura.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
van Niekerk, JL1
Hendriks, T1
Gevers Leuven, JA1
Havekes, L1
de Boer, HH1

Other Studies

1 other study available for meglutol and Hyperlipemia

ArticleYear
The lipid-lowering effects of 3-hydroxy-3-methylglutaric acid and bile acid drainage in WHHL rabbits.
    Clinical science (London, England : 1979), 1984, Volume: 67, Issue:4

    Topics: Animals; Bile Acids and Salts; Cells, Cultured; Cholesterol; Cholestyramine Resin; Drainage; Female;

1984